Baker Bros. Decreases Exposure at Viropharma
Julian and Felix Baker‘s hedge fund, Baker Bros. Advisors, now holds around 4.4 million shares of Viropharma Inc (NASDAQ:VPHM), a newly amended...
Posts Tagged ‘ViroPharma Inc. (VPHM)’
Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Getting Closer
When you have $5.5 billion in your wallet, it’s understandable if there’s a hankering to spend some of it. French drugmaker Sanofi SA (ADR...
Sanofi SA (ADR) (SNY), Shire PLC (ADR) (SHPG): Making Sense of the Drama About Viropharma Inc (VPHM)
In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well...
Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors
Looking for the best-performing sector in this year’s big market rally? It may just be the biotech sector, which has erupted with astronomical gains...
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Hedge Funds Aren’t Crazy About Charles River Laboratories (CRL) Anymore
In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading...
Is Questcor Pharmaceuticals Inc (QCOR) Going to Burn These Hedge Funds?
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) investors: listen up. In today’s marketplace, there are a multitude of methods shareholders can use to watch...
Hedge Funds Are Selling Arena Pharmaceuticals, Inc. (ARNA)
Here’s why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) might be a sell. Now, according to many market players, hedge funds are viewed as delayed,...
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated...
Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a safe stock to buy now? Hedge funds are turning bullish. The number of long hedge fund bets increased by...
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish...
Halozyme Therapeutics, Inc. (HALO), Viropharma Inc (VPHM): Three Horrendous Health-Care Stocks This Week
You can’t win all of the time. This week saw its fair share of losing stocks in the health-care arena. Here are three of the biggest losers of all...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing...
Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World
The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016....
Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short. Its...
Viropharma Inc (VPHM), Actavis Inc (ACT), Akorn, Inc. (AKRX): Can This Experimental Drug Be Brought Back From the Dead?
Five years ago, Viropharma Inc (NASDAQ:VPHM) had everything going for it. Sales of the company’s lead drug, Vancocin — an FDA-approved treatment...
Arena Pharmaceuticals, Inc. (ARNA): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds’ portfolio at the end of the first quarter of 2013. ARNA investors should pay attention...
Do Hedge Funds and Insiders Love Synageva BioPharma Corp (GEVA)?
Synageva BioPharma Corp (NASDAQ:GEVA) has experienced an increase in hedge fund sentiment in recent months. At the moment, there are dozens of metrics...
Onyx Pharmaceuticals, Inc. (ONXX), Cyberonics, Inc. (CYBX) Among Elite Investor’s Top Five Positions
To say that William Leland Edwards of Palo Alto Investors invest heavily in healthcare stocks would be, well, a bit of an understatement. The fund’...
Micron Technology, Inc. (MU), Pfizer Inc. (PFE): Whoa! These Stocks Outpaced the Dow
The Dow Jones Industrial Average rose by 90 points on Friday — the exact amount it fell the day before — on hopes that a deal between the...
This Hedge Fund Was a Beast Last Quarter
We track over 400 funds and investors, and have calculated the value-weighted returns for all funds in the 1500 largest stocks, while compiling a list...
Steve Cohen’s SAC Capital Under Investigation for $14M in Suspicious Trades
Steve Cohen‘s SAC Capital Advisors is under investigation for more than $14 million in suspicious trades according to Bloomberg. FINRA is Questioning...
